Bhat Abdul, Turnbull Amy, Aijaz Abir, Badshah Amit
Internal Medicine, University Hospitals Bristol and Weston, Weston-super-Mare, GBR.
Acute and General Internal Medicine, University Hospitals Bristol and Weston, Weston-super-Mare, GBR.
Cureus. 2024 Sep 5;16(9):e68727. doi: 10.7759/cureus.68727. eCollection 2024 Sep.
Hyperkalaemia is a relatively common medical emergency that necessitates prompt and urgent intervention. There is an ongoing debate over the precise threshold for treating hyperkalaemia due to variability in clinical scenarios. This case report highlights the need to differentiate true hyperkalaemia from pseudohyperkalaemia by analysing serum and plasma potassium levels, thus avoiding unnecessary treatment and the risk of iatrogenic hypokalemia. This case report discusses an 89-year-old male who presented with recurrent falls and fluctuating serum potassium levels but showed no symptoms of hyperkalaemia and had no relevant drug history. Further investigation revealed an underlying myeloproliferative neoplasm with thrombocytosis, leading to the diagnosis of pseudohyperkalaemia, reflected by a significant discrepancy between serum and plasma potassium levels, showcasing the importance of considering pseudohyperkalaemia in patients with haematological malignancies and thrombocytosis.
高钾血症是一种相对常见的医疗急症,需要迅速且紧急的干预。由于临床情况的变异性,对于治疗高钾血症的精确阈值一直存在争论。本病例报告强调了通过分析血清和血浆钾水平来区分真性高钾血症和假性高钾血症的必要性,从而避免不必要的治疗以及医源性低钾血症的风险。本病例报告讨论了一名89岁男性,他反复跌倒且血清钾水平波动,但无高钾血症症状且无相关用药史。进一步检查发现潜在的骨髓增殖性肿瘤伴血小板增多症,导致假性高钾血症的诊断,这表现为血清和血浆钾水平之间存在显著差异,凸显了在血液系统恶性肿瘤和血小板增多症患者中考虑假性高钾血症的重要性。